The new drug Culmerciclib has been launched
The new drug Culmerciclib has been launched Culmerciclib (brand name: Sitanicina®) is the first global triple inhibitor of CDK2/4/6, developed by Zhengda Tianqing under China Biopharmaceuticals. I
The new drug Culmerciclib has been launched Culmerciclib (brand name: Sitanicina®) is the first global triple inhibitor of CDK2/4/6, developed by Zhengda Tianqing under China Biopharmaceuticals. I